220 related articles for article (PubMed ID: 31494160)
21. Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis.
Saini D; Fazil M; Ali MM; Baboota S; Ali J
Drug Deliv; 2015; 22(6):823-36. PubMed ID: 24725026
[TBL] [Abstract][Full Text] [Related]
22. Characterization and carboplatin loaded chitosan nanoparticles for the chemotherapy against breast cancer in vitro studies.
Khan MA; Zafaryab M; Mehdi SH; Quadri J; Rizvi MM
Int J Biol Macromol; 2017 Apr; 97():115-122. PubMed ID: 28082219
[TBL] [Abstract][Full Text] [Related]
23. Interfacial Phenomenon Based Biocompatible Alginate-Chitosan Nanoparticles Containing Isoniazid and Pyrazinamide.
Kushwaha K; Dwivedi H
Pharm Nanotechnol; 2018; 6(3):209-217. PubMed ID: 29938624
[TBL] [Abstract][Full Text] [Related]
24. PEGylated Erlotinib HCl Injectable Nanoformulation for Improved Bioavailability.
Bhargave H; Nijhawan H; Yadav KS
AAPS PharmSciTech; 2023 Apr; 24(4):101. PubMed ID: 37038015
[TBL] [Abstract][Full Text] [Related]
25. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
Shaji J; Menon I
Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
[TBL] [Abstract][Full Text] [Related]
26. Rifampicin loaded chitosan nanoparticle dry powder presents an improved therapeutic approach for alveolar tuberculosis.
Rawal T; Parmar R; Tyagi RK; Butani S
Colloids Surf B Biointerfaces; 2017 Jun; 154():321-330. PubMed ID: 28363192
[TBL] [Abstract][Full Text] [Related]
27. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
He Y; Su Z; Xue L; Xu H; Zhang C
J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
[TBL] [Abstract][Full Text] [Related]
28. Methotrexate-loaded PEGylated chitosan nanoparticles: synthesis, characterization, and in vitro and in vivo antitumoral activity.
Chen J; Huang L; Lai H; Lu C; Fang M; Zhang Q; Luo X
Mol Pharm; 2014 Jul; 11(7):2213-23. PubMed ID: 24164427
[TBL] [Abstract][Full Text] [Related]
29. Sunitinib loaded chitosan nanoparticles formulation and its evaluation.
Joseph JJ; Sangeetha D; Gomathi T
Int J Biol Macromol; 2016 Jan; 82():952-8. PubMed ID: 26522243
[TBL] [Abstract][Full Text] [Related]
30. Treatment of oxidative stress-induced pain and inflammation with dexketoprofen trometamol loaded different molecular weight chitosan nanoparticles: Formulation, characterization and anti-inflammatory activity by using in vivo HET-CAM assay.
Öztürk AA; Kıyan HT
Microvasc Res; 2020 Mar; 128():103961. PubMed ID: 31758946
[TBL] [Abstract][Full Text] [Related]
31. Preparation of Mesalamine Nanoparticles Using a Novel Polyurethane- Chitosan Graft Copolymer.
Mirabbasi F; Dorkoosh FA; Moghimi A; Shahsavari S; Babanejad N; Seifirad S
Pharm Nanotechnol; 2017; 5(3):230-239. PubMed ID: 29110631
[TBL] [Abstract][Full Text] [Related]
32. Effects of Chemical Conjugation of l-Leucine to Chitosan on Dispersibility and Controlled Release of Drug from a Nanoparticulate Dry Powder Inhaler Formulation.
Muhsin MD; George G; Beagley K; Ferro V; Wang H; Islam N
Mol Pharm; 2016 May; 13(5):1455-66. PubMed ID: 26998555
[TBL] [Abstract][Full Text] [Related]
33. Fabrication of letrozole formulation using chitosan nanoparticles through ionic gelation method.
Gomathi T; Sudha PN; Florence JAK; Venkatesan J; Anil S
Int J Biol Macromol; 2017 Nov; 104(Pt B):1820-1832. PubMed ID: 28185930
[TBL] [Abstract][Full Text] [Related]
34. Bio-fabrication and statistical optimization of polysorbate 80 coated chitosan nanoparticles of tapentadol hydrochloride for central antinociceptive effect: in vitro-in vivo studies.
Patil GB; Surana SJ
Artif Cells Nanomed Biotechnol; 2017 May; 45(3):505-514. PubMed ID: 27017892
[TBL] [Abstract][Full Text] [Related]
35. Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor.
Ignjatović NL; Penov-Gaši KM; Wu VM; Ajduković JJ; Kojić VV; Vasiljević-Radović D; Kuzmanović M; Uskoković V; Uskoković DP
Colloids Surf B Biointerfaces; 2016 Dec; 148():629-639. PubMed ID: 27694053
[TBL] [Abstract][Full Text] [Related]
36. RETRACTED: Enhanced antitumor efficacy of 5-fluorouracil loaded methoxy poly(ethylene glycol)-poly(lactide) nanoparticles for efficient therapy against breast cancer.
Yuan Z; Qu X; Wang Y; Zhang DY; Luo JC; Jia N; Zhang ZT
Colloids Surf B Biointerfaces; 2015 Apr; 128():489-497. PubMed ID: 25779606
[TBL] [Abstract][Full Text] [Related]
37. PEGylated polypeptide lipid nanocapsules to enhance the anticancer efficacy of erlotinib in non-small cell lung cancer.
Kim J; Ramasamy T; Choi JY; Kim ST; Youn YS; Choi HG; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2017 Feb; 150():393-401. PubMed ID: 27825759
[TBL] [Abstract][Full Text] [Related]
38. In Situ Gel Loaded with Chitosan-Coated Simvastatin Nanoparticles: Promising Delivery for Effective Anti-Proliferative Activity against Tongue Carcinoma.
Kurakula M; Naveen NR
Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32283782
[TBL] [Abstract][Full Text] [Related]
39. Anticancer efficacy of 6-thioguanine loaded chitosan nanoparticles with or without curcumin.
Rajashekaraiah R; Kumar PR; Prakash N; Rao GS; Devi VR; Metta M; Narayanaswamy HD; Swamy MN; Satyanarayan K; Rao S; Rathnamma D; Sahadev A; Sunilchandra U; Santhosh CR; Dhanalakshmi H; Kumar SN; Ruban SW; Kalmath GP; Gomes AR; Kumar KRA; Govindappa PK
Int J Biol Macromol; 2020 Apr; 148():704-714. PubMed ID: 31954127
[TBL] [Abstract][Full Text] [Related]
40. Rifaximin - Chitosan Nanoparticles for Inflammatory Bowel Disease (IBD).
Kumar J; Newton AMJ
Recent Pat Inflamm Allergy Drug Discov; 2017; 11(1):41-52. PubMed ID: 28034350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]